Surviving Cancer відкриті
[search 0]
більше
Download the App!
show episodes
 
OUR MISSION To facilitate tangible improvements in the lives of people who have been affected by cancer(s), by providing them and their loved ones the necessary survival tools, education, support and advocacy so that they can become responsible for and take an active role in their own medical care and wellbeing. OUR GOAL Our goal is to teach all people affected by cancer, including those with multiple cancers and/or rare cancers, to become CANCER THRIVERS.
  continue reading
 
Loading …
show series
 
NBA superstar Grant Hill, also an Atlanta Hawks co-owner, and African American health advocate, has teamed up with Dendreon to combat the prostate cancer racial disparities experienced by African American men. He discusses, along with Cancer ABCs CEO Joel Nowak, how men, particularly African American men, can combat the disparities. They focus on h…
  continue reading
 
Overall survival and cancer-specific survival for those with node-positive prostate cancer treated with surgery lived longer than those who elected radiation treatment. Men diagnosed with node positive prostate cancer need to decide if they want to include a targeted treatment to their prostate gland along with a systemic treatment like hormonal th…
  continue reading
 
https://ard.bmj.com/content/early/2021/08/22/annrheumdis-2021-220597 As per the link above, individuals taking the drug methotrexate experience an up to 62% reduced rate of an immunological response when given a mRNA Covid-19 vaccination like to Pfizer and Moderna vaccines. This finding suggests that patients on methotrexate may need alternate vacc…
  continue reading
 
When you are first diagnosed with cancer, when the doctor says to you have cancer, you are likely to have many different responses. Among these first possible responses are fear, apprehension, disbelief, sadness, anger, dread, or even denial. Any and all of these reactions are reasonable and normal. The question is how do you chose to deal with the…
  continue reading
 
Joel Nowak and Shane Norris discuss his unusual Covid Pandemic Journey with a new prostate cancer diagnosis. Shane, a well-respected music producer and gig worker, joined with other New Orleans artists to raise funds for out-of-work musicians. As he began to create a fund raising vehicle he was diagnosed with prostate cancer. Shane shares the exper…
  continue reading
 
Radiopharmaceutical scans (PETS) are a vital tool in our fight against cancer. These special PET scans allow us to make earlier cancer diagnoses while a cancer is still contained in the original organ. With an earlier diagnosis, treatments can still stop the cancer before it is able to move to other parts of the body, or become metastatic. These sp…
  continue reading
 
Joel T Nowak from Cancer ABCs discusses with Dr. Rana McKay, Associate Professor of Medicine at the Moores Cancer Center at the University of California in San Diego, her recently published article that analysizes real world data that demonstrates that Provenge (sipuleucel-T), an immune therapy for castrate resistant metastatic prostate cancer (mCR…
  continue reading
 
One of the most common question men with prostate cancer ask us at Cancer ABCs is if they can stop their hormone therapy (ADT) when they go on a second generation hormone treatment like abiraterone (Zytiga). A recent analysis of the SPARE Trial points us in the direction that it might be possible to halt ADT when you are taking Zytiga. SPARE was a …
  continue reading
 
Men who have a local prostate cancer recurrence, or their PSA starts increasing, after having prostate cancer surgery (a radical prostatectomy), the treatment of choice is considered salvage radiotherapy (SRT). In the post prostatectomy setting, SRT may impose significant risks and complications. Potential complications or side effects can include …
  continue reading
 
Genetic testing plays a major role in identifying an individual's risk for developing cancer as well as the management of many different cancers, including prostate cancer. It's important that we patients know the limits of a key federal privacy law that is supposed to protect us when we do have a genetic test. In June, 2020, there was a new set of…
  continue reading
 
Written Transcript at https://www.cancerabcs.org/transcript-racial-disparities-in-prostate-cancer-clinical-trials Joel T Nowak interviews Emily Rencsok, an MD/PhD student at the Harvard T.H. Chan School of Public Health. They discuss the findings of a recent publication which she was the first author that analyzed 59 prostate cancer clinical trials…
  continue reading
 
Written Transcript at: https://www.cancerabcs.org/transcript-pc-treatment-in-the-covid19-era Joel Nowak discusses how one doctor, Dr. Emmanuel Antonarakis from The Johns Hopkins Hospital has modified his prostate cancer treatments in the era of the coronavirus. Joel shares how Dr. Antonarakis has moved to using telemedicine when possible, the chang…
  continue reading
 
Written Transcript at: https://www.cancerabcs.org/transcript-provengesurvivaladvantage Dr. Tim Richardson talks with Joel Nowak talk about the real survival advantages that the immunotherapy known as Provenge (sipuleucel-T) offers to men, especially men who get the therapy while their PSA is low (Schellhammer data) and men with an African-American …
  continue reading
 
Written Transcript at: https://www.cancerabcs.org/transcript-urinary-incontinence-post-radical-prostatectomy-solutions Joel Nowak discusses why men who have a radical prostatectomy, or the surgical removal of their prostate gland to treat prostate cancer often suffer urinary incontinence. Urinary incontinence negatively affects a man's quality of l…
  continue reading
 
Written Transcript at: https://www.cancerabcs.org/transcript-oncotype-prostate-sore-and-active-surveillance Mr. Anson Tharayanil, a Medical Science Liaison from Genomic Health rejoins Joel Nowak from Cancer ABCs to talk about another test for men diagnosed with low or favorable medium risk prostate cancer, the Oncotype DX Genomic Prostate Score. Th…
  continue reading
 
Written Transcript at: https://www.cancerabcs.org/transcript-using-the-genomic-health-arv-7-test-when-you-arev-aking-xtandi-zytiga-or-erleada In this podcast Anson Tharayanil, a Meical Science Liaison from Genomic Health, Inc. talks with Joel Nowak about their test, the Oncotype DX ARV-7 Nucleus Detect Test for men with castrate resistant metastati…
  continue reading
 
Dr. Ken Pienta from The Johns Hopkins Hospital explains all about metastatic prostate Written Transcript at: https://www.cancerabcs.org/transcript-dr-ken-pienta-discusses-what-is-metastatic-prostate-cancercancer and how it spreads or metastasizes. He Includes in his discussion how prostate cancer is staged, how cancer migrates from the prostate gla…
  continue reading
 
Written Transcript at: https://www.cancerabcs.org/transcript Mark Hall was diagnosed with metastatic prostate cancer with a PSA of 4,400 and a Gleason Score of 8. Despite these terrible numbers he has been thriving the last four years with an undetectable PSA and a fantastic quality of life! Mark shares his journey, where under the guidance of Dr. …
  continue reading
 
Hearing that someone you know or a loved one has been diagnosed with cancer is often scary. Not only are you concerned about their health, but many of us are not sure how to speak with them or offer them help. We want to reach out to them, but we don't know if we should talk about their cancer. We also don't know how we can help them. Joel T. Nowak…
  continue reading
 
Joel T Nowak from Cancer ABCs along with oncology nurse Fran Fanning (co-owner of Heavenly Hash) participated in a prostate cancer patient conference sponsored by Prostate Cancer International. The conference was held in Ft. Meyers Florida in March of 2019. They offered a live presentation that described how hormone therapy worked, how it is achiev…
  continue reading
 
Joel Nowak from Cancer ABCs interviews Michael Singer, a male breast cancer thriver. Michael, diagnosed at age 50, shares his journey and his advocacy as a man with breast cancer. Three years before learning that he had breast cancer his sister, with whom he lived, was diagnosed with metastatic breast cancer. She succumbed to the disease one year a…
  continue reading
 
Joel T Nowak interviews Dr. Maryanne Sadar, who has developed a novel drug target, an investigational treatment, that is a first in class hormone therapy operating on the N Terminal Domain of the androgen receptor. The investigational treatment, Epi-506, is being tested on men with advanced, metastatic prostate cancer. Dr. Sadar describes how the d…
  continue reading
 
Joel Nowak talks with Dr. Corrie Painter. who is an eight-year Cancer Thriver with Angiosarcoma, a very rare and lethal cancer of the interior of the blood vessels. Dr. Painter is a researcher with the Broad Institute of MIT and Dana Farber. She is instrumental in designing and executing the Broad’s research project, The Angiosarcoma Project as wel…
  continue reading
 
Joel Nowak interviews Dr. Eli Van Allen, a medical oncologist specializing in prostate cancer, from the Broad Institute, an MIT and Dana Farber collaboration and the Dana Farber Hospital about the Metastatic Prostate Cancer Project. The project is a research project created jointly with patients that are reaching out to men with metastatic prostate…
  continue reading
 
Loading …

Короткий довідник